- $755.42m
- $2.17bn
- CNY7.41bn
- 46
- 76
- 96
- 84
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,789 | 4,829 | 6,190 | 7,065 | 7,413 |
Cost of Revenue | |||||
Gross Profit | 939 | 1,076 | 1,438 | 1,358 | 1,292 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,626 | 4,725 | 6,155 | 6,944 | 9,395 |
Operating Profit | 163 | 104 | 35 | 121 | -1,982 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -125 | -2,582 | 665 | -630 | -2,486 |
Provision for Income Taxes | |||||
Net Income After Taxes | -131 | -2,691 | 554 | -764 | -2,600 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -182 | -2,709 | 500 | -776 | -2,644 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -182 | -2,709 | 494 | -776 | -2,644 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.254 | -3.69 | 0.63 | -0.875 | -1.58 |